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Recent increases in the prevalence of asthma 
and other allergic diseases have prompted inves-
tigators to consider the role of the environ-
ment in the genesis of atopy (von Mutius, 2009; 
Horner, 2010). Modern public health practices 
have eliminated many of the microbial threats 
for humans. The hygiene hypothesis proposes 
that higher allergic disease prevalence rates in 
developed countries are an unintended conse-
quence of this deficiency in the timing, quantity, 
and quality of immune provocation by microbes 
(Holt and van den Biggelaar, 2010; Horner, 2010; 
von Mutius, 2010).
Several investigators have shown that en-
dotoxin is ubiquitously distributed (Gereda et al., 
2001; Gehring et al., 2002; Rabinovitch et al., 
2005; Dassonville et al., 2008), and several have 
reported that infants raised in homes with high 
endotoxin levels were less likely to develop 
allergic stigmata, although others have been un-
able to confirm this association (Gereda et al., 
2000; Braun-Fahrländer et al., 2002; Tse and 
Horner, 2008). Apart from endotoxin, homes 
contain a variety of other microbial products 
that are potent stimulants of the innate immune 
system (Roy et al., 2003; van Strien et al., 2004). 
In this vein, we have previously reported that 
house dust extracts (HDEs) contain ligands that 
activate DCs by toll-like receptor 2 (TLR2)–, 
TLR4-, and TLR9-dependent pathways (Boasen 
et al., 2005; Batzer et al., 2007). We have fur-
ther established that HDEs have the potential 
to function as Th2 adjuvants in mice receiving 
intranasal (i.n.) OVA vaccinations (Ng et al., 2006; 
Lee et al., 2011).
NKT cells with an invariant TCR- chain 
(invariant NKT cells [iNKT cells]) recognize gly-
colipids presented by CD1d, an MHC class I–like 
antigen-presenting molecule, and their rapid and 
explosive production of cytokines is more similar 
to innate immune cells than to the responses   
of  adaptive  immune  cells  (Kronenberg,  2005; 
Tupin et al., 2007). The first and most potent 
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Invariant NKT cells (iNKT cells) are a unique subset of T lymphocytes that rapidly carry out 
effector functions. In this study, we report that a majority of sterile house dust extracts 
(HDEs) tested contained antigens capable of activating mouse and human iNKT cells. HDEs 
had adjuvant-like properties in an ovalbumin (OVA)-induced asthma model, which were 
dependent on V14i NKT cells, as vaccinated animals deficient for iNKT cells displayed 
significantly attenuated immune responses and airway inflammation. Furthermore, the 
administration of HDEs together with OVA mutually augmented the synthesis of cytokines 
by V14i NKT cells and by conventional CD4+ T cells in the lung, demonstrating a profound 
immune response synergy for both Th2 cytokines and IL-17A. These data demonstrate that 
iNKT cell antigens are far more widely dispersed in the environment than previously antici-
pated. Furthermore, as the antigenic activity in different houses varied greatly, they further 
suggest that iNKT cell responses to ambient antigens, particular to certain environments, 
might promote sensitization to conventional respiratory allergens.
© 2011 Wingender et al.  This article is distributed under the terms of an At-
tribution–Noncommercial–Share Alike–No Mirror Sites license for the first six 
months after the publication date (see http://www.rupress.org/terms). After six 
months it is available under a Creative Commons License (Attribution–Noncom-
mercial–Share Alike 3.0 Unported license, as described at http://creativecommons 
.org/licenses/by-nc-sa/3.0/).
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Batzer et al., 2007). However, as seen in Fig. 1, the V14i 
NKT cell hybridomas did not respond to TLR2 or TLR4 
ligands. Moreover, these hybridomas were nonresponsive to 
HDEs, unless plates were precoated with soluble CD1d (un-
published data). Additionally, both the type II NKT cell hy-
bridoma 24 (CD1d restricted without the V14i TCR) and 
the OVA-specific non-NKT cell hybridoma B3Z did not 
respond to HDEs in the CD1d-coated plate assay (unpub-
lished data). Collectively, these findings indicate that HDEs 
induced CD1d- and TCR-dependent IL-2 production by sev-
eral V14i NKT cell hybridomas. Moreover, variable respon-
siveness of the hybridomas toward the eight HDEs indicates 
that the particular  V gene can influence the response, as has 
been observed with model antigens (Scott-Browne et al., 2007; 
Pellicci et al., 2009; Raju et al., 2009). Finally, this variable 
response pattern suggests that different HDEs may contain 
different antigens with varying affinities for the TCRs ex-
pressed by these iNKT cell hybridomas.
iNKT cell antigen to be identified was -galactosylceramide 
(-GalCer), a synthetic version of a glycolipid originally 
isolated from a marine sponge (Bendelac et al., 1997). Subse-
quently, iNKT cell antigens have been found in only two 
bacteria, Sphingomonas species, which based on the chemical 
similarity are the likely source of the original sponge antigen, 
and Borrelia burgdorferi, which is the causative agent of Lyme 
disease (Kinjo et al., 2006). However, the distribution and 
prevalence of iNKT cell antigens in the microbiota and in the 
wider environment, and whether the presence of these anti-
gens influences asthma or autoimmunity, remain to be deter-
mined. iNKT cells have been implicated in directing many 
types of immune responses in mice, including several asthma 
models (Lisbonne et al., 2003; Bilenki et al., 2004; Pichavant 
et al., 2008; Kim et al., 2009) and a model for chronic obstruc-
tive pulmonary disease initiated by virus infection (Kim et al., 
2008). Furthermore, airway challenge with glycolipid anti-
gens induced pathological features of asthma in MHC class 
II–deficient mice that lack conventional CD4+ T cells (Meyer 
et al., 2006). V24i NKT cells also have been implicated in 
the pathogenesis of asthma in humans (Akbari et al., 2006), 
although controversy remains about the role and especially 
about the magnitude of their increased frequency within the 
lungs of asthmatics (Hachem et al., 2005; Pham-Thi et al., 
2006; Michel et al., 2007; Thomas et al., 2010). Given these 
considerations, the current series of investigations assessed 
the distribution and prevalence of iNKT cell antigens in in-
door environments by analyzing HDEs from different homes 
and determined whether iNKT cells contribute to the adju-
vant activities of these HDEs in a mouse airway inflamma-
tion model.
RESULTS
HDEs contain antigens for V14i NKT cells
To address whether HDEs contain iNKT cell antigens, we 
tested their ability to stimulate mouse V14i NKT cell hy-
bridomas in a cell-free, CD1d-dependent, antigen presenta-
tion assay. Hybridoma DN3A4-1.2 utilizes the V8.2 chain, 
expressed by 55% of mouse iNKT cells (Bendelac et al., 
1997; Benlagha et al., 2000; Matsuda et al., 2000). Seven out 
of eight HDEs stimulated the release of IL-2 by DN3A4-1.2 
hybridoma cells when added to a plate coated with soluble 
mouse CD1d (Fig. 1 A). Seven out of eight HDEs also in-
duced IL-2 release by 2H4 hybridoma cells (Fig. 1 B), which 
express V7, used by 14% of primary V14i NKT cells 
(Bendelac et al., 1997; Benlagha et al., 2000; Matsuda et al., 
2000). In contrast, only four out of seven HDEs activated 
DN3A4-1.4 hybridoma cells (Fig. 1 C), which express the 
V10 chain, but primary V14i NKT cells rarely express this 
V (Bendelac et al., 1997; Benlagha et al., 2000; Matsuda 
et al., 2000). Furthermore, DN3A4-1.4 hybridoma cells are 
less capable of recognizing -GalCer variants with substitu-
tions at the 3 and 4 positions of the galactose sugar com-
pared with their V8.2- and V7-expressing counterparts 
(Raju et al., 2009). We have previously reported that HDEs 
contain several TLR ligands (TLR-Ls; Boasen et al., 2005; 
Figure 1.  HDEs contain antigens for V14i NKT cells. (A–C) Micro-
titer wells coated with CD1d monomers were left untreated (no AG) or 
were incubated with -GalCer or the indicated (x axis) HDEs for 18–22 h. 
Wells were washed and incubated with 5 × 104 of the indicated iNKT cell 
hybridomas (y axis) for 22–24 h. The V usage of each hybridoma is indi-
cated in the top right of each graph. The IL-2 concentration in the super-
natant was determined by ELISA. The depicted values represent the mean 
of the observed ELISA replicates. Background values have been subtracted. 
None of the iNKT cell hybridomas responded to HDEs in the absence of 
CD1d (not depicted). Representative data of at least two experiments are 
shown. nd, not determined.JEM Vol. 208, No. 6 
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HDE-loaded BM-derived DCs (BM-DCs) stimulate mouse 
iNKT cells in vivo
To determine whether HDEs could activate mouse V14i 
NKT cells in vivo, we immunized mice with BM-DCs pulsed 
with an HDE standard prepared from pooled samples found 
to have high levels of V14i NKT cell antigen by the APC-
free hybridoma assay presented in Fig. 1 (hereafter HDE stan-
dard; see Materials and methods). As V14i NKT cells also can 
be activated by cytokines from APCs stimulated by TLR-L,   
in  a  CD1d-independent  manner,  we  used  antigen-pulsed 
BM-DCs derived from MyD88 and Trif double-deficient 
animals (BM-DCDKO), which cannot respond to any known 
TLR-L (Hoebe et al., 2003). BM-DCDKO pulsed with -GalCer 
was used as a positive control for these experiments. BM-DCDKO 
pulsed with LPS provided a negative control because these 
BM-DCDKO should not be able to provide the required cyto-
kines for V14i NKT cell activation in the absence of exoge-
nous antigen. 14–16 h after the injection of BM-DCDKO, iNKT 
cells from recipient mice were analyzed. Challenge with 
BM-DCDKO loaded with -GalCer (BM-DCDKO/-GalCer) 
led to a significant reduction in the frequency of V14i NKT 
cells (Fig. 3 A) and to the up-regulation of CD69 on the iNKT 
cells that could still be detected (Fig. 3, B and C), which are 
both indicators of iNKT cell activation. In contrast, BM-DCDKO 
loaded with LPS had, as expected, no effect on either parameter 
(Fig. 3, A–C). Compared with challenge with BM-DCDKO/ 
-GalCer,  injection  of  BM-DCDKO  loaded  with  HDE 
(BM-DCDKO/HDE) had a smaller but nonetheless significant 
effect on  V14i NKT cell recovery (Fig. 3 A), and these iNKT 
cells displayed increased expression of CD69 (Fig. 3, B and C). 
Furthermore, BM-DCDKO/HDE challenge induced the pro-
duction of IFN- (Fig. 3 D) and IL-4 (Fig. 3 E) by iNKT 
cells.  In  previous  experiments,  although  IFN-  synthesis 
could be elicited from  V14i NKT cells activated by self-antigen 
or solely by cytokines, IL-4 was correlated with foreign antigen 
activation (Nagarajan and Kronenberg, 2007; Tupin et al., 2008).
To address the CD1d dependency of iNKT cell activation 
by BM-DCDKO/-GalCer and BM-DCDKO/HDE in vivo, 
we repeated the aforementioned experiments in the presence 
of blocking -CD1d antibodies. This blockade significantly 
reduced the activation of iNKT cells by either -GalCer or 
HDE, as measured by up-regulation of CD69 and cytokine 
production (Fig. 3, F and G). Importantly, the -CD1d   
antibody–mediated impairment of iNKT cell activation by 
BM-DCDKO/HDE was for all parameters and in all experi-
ments comparable with or more pronounced than the reduc-
tion observed with the stimulation by BM-DCDKO/-GalCer. 
Collectively, these data suggest an exogenous antigen-depen-
dent activation of V14i NKT cells in vivo by BM-DCDKO 
pulsed with HDEs.
NK cells can be activated downstream of V14i NKT cell 
activation, although after exposure to HDEs, it is possible that 
NK cell activation occurs independently of V14i NKT cells. 
Therefore, to assess the impact of HDE-mediated iNKT cell 
activation on NK cells, we also analyzed CD69 expression on 
these cells. After BM-DCDKO/HDE injection, a clear increase 
HDEs stimulate human iNKT cell lines
We  next  determined  whether  human  V24i  NKT  cell 
lines expanded from PBMC-recognized antigens within HDEs. 
Indeed, 8 of the 12 HDEs tested induced cytokine produc-
tion by a human iNKT cell line (Fig. 2 A). Similar results 
were obtained with a second V24i NKT cell line (un-
published data). Moreover, of the 12 tested HDEs, 9 induced 
similar responses by human and mouse iNKT cells (Fig. 2, 
A  and  B).  This  high  degree  of  concordance  between 
HDE-induced responses by the human iNKT cell line and 
mouse iNKT cell hybridoma DN3A4-1.2 (V14/V8.2) 
suggests that they were responding to the same antigen or 
antigens. Consistent with this view, human V11, the most 
common TCR- expressed by human V14i NKT cells, 
is an orthologue of mouse V8.2 (Bendelac et al., 1997; 
Kronenberg, 2005).
Figure 2.  HDEs stimulate human iNKT cell lines. (A) Human PBMCs 
were left untreated (no AG) or were incubated with -GalCer or the indi-
cated (x axis) HDEs. After 20 h, cells were washed, and 2 × 105 PBMCs 
were incubated with 4 × 104 iNKT cells of the human iNKT cell line 59 for 
72 h. The GM-CSF concentration in the supernatant was determined by 
ELISA. Similar results were obtained with the human iNKT cell line 2225 
(not depicted). (B) Cell culture plates, coated with CD1d monomers, were 
left untreated (no AG) or were incubated with -GalCer or the indicated 
(x axis) HDEs. After 20 h, plates were washed and incubated with 5 × 104 
of the mouse iNKT cell hybridoma DN3A4-1.2 for 22 h. The IL-2 concen-
tration in the supernatant was determined by ELISA. The depicted values 
represent the mean of the observed ELISA replicates. Background values 
have been subtracted. Representative data of at least two experiments are 
shown. Note that samples 1–3 are the same as those tested with DN3A4-
1.2 in Fig. 1 A, whereas samples 9–17 were obtained from different 
houses from those analyzed in Fig. 1.1154 NKT cell antigens in dust induce inflammation | Wingender et al.
abrogated NK cell CD69 up-regulation 
(Fig. 3 H). These data indicated that the 
NK cell activation after BM-DCDKO/
HDE delivery was mainly  V14i NKT 
cell driven.
V14i NKT cells contribute to the 
adjuvant effect of HDE
HDEs have previously been found to be potent Th2-biasing 
mucosal adjuvants in a mouse asthma model (Boasen et al., 
2005; Ng et al., 2006; Batzer et al., 2007; Lee et al., 2011). 
Therefore, we determined whether V14i NKT cells helped 
mediate the Th2 adjuvant activity of HDEs. To this end, 
BALB/c mice and J18/ mice were i.n. vaccinated three 
times with chicken OVA alone or together with HDE stan-
dard.  Sensitized  mice  were  then  airway  challenged  twice 
with OVA alone, and the parameters of OVA-specific im-
munity and airway inflammation were analyzed 24 h after the 
last challenge (experimental outline in Fig. 4 A). Wild-type 
in CD69 expression by NK cells was observed (Fig. S1). To 
test whether other innate immune sensors beside TLRs could 
induce such activation of NK cells independent of V14i NKT 
cell activity, we injected the BM-DCDKO/HDE into J18/ 
mice, which lack V14i NKT cells (Cui et al., 1997), or into 
CD1d/ mice. Only a small proportion of NK cells from 
J18/ mice responded by up-regulating their expression of 
CD69 (Fig. S1), and similar results were obtained in CD1d/ 
recipients (not depicted). Consistent with these findings, the 
NK cell trans-activation was dependent on iNKT cell rec-
ognition of CD1d as blocking with an -CD1d antibody 
Figure 3.  HDE-loaded BM-DCs stimulate 
mouse iNKT cells in vivo. DCs were gener-
ated with GM-CSF from the BM of MyD88 
and Trif double-deficient animals (BM-DCDKO; 
DC in the graphs). BM-DCDKO were washed 
and incubated with the indicated substances 
(50 µl/ml HDE, 150 ng/ml LPS, or 50 ng/ml  
-GalCer) for 5 h, and 5 × 105 BM-DCDKO were 
injected i.v. into C57BL/6 mice. 12–15 h later, 
splenic iNKT cells were analyzed. (A) Relative 
proportion of iNKT cells in the spleen.  
(B and C) Representative expression of CD69 
by splenic iNKT cells from single mice (B) and 
a summary of data from at least three mice 
per group from a representative experiment (C). 
The numbers in the histogram denote the 
geometric mean values of CD69 on iNKT cells. 
(A–C) Representative data from one of four 
independent experiments, with three to four 
mice per group, are shown. (D and E) IFN- 
(D) and IL-4 expression (E) by splenic iNKT 
cells after challenge with the indicated BM-
DCDKO. Background values have been sub-
tracted. The graphs in D and E summarize 
data from three and two independent experi-
ments, respectively, with two to four mice per 
group. (F–H) Mice were injected with 200 µg 
-CD1d antibody (1B1) together with BM-
DCDKO loaded with the indicated antigens. Up-
regulation of CD69 on iNKT cells (F) or NK 
cells (H) and production of the indicated cyto-
kines by iNKT cells (G) are depicted. The differ-
ence in cytokines production (G) with and 
without -CD1d antibody treatment was 
statistically significant for all cytokines and 
BM-DCDKO challenges. Representative data 
from one of two independent experiments, 
with three to five mice per group, are shown. 
Error bars indicate mean ± SEM.JEM Vol. 208, No. 6 
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Figure 4.  V14i NKT cells contribute to the adjuvant effect of HDE during allergen-induced airway inflammation. (A) Experimental outline: 
BALB/c mice and J18-deficient mice on the BALB/c background (J18/) were sensitized three times, once per week (days 0, 7, and 14) with chicken 
OVA alone (100 µg/mouse) or together with HDE standard (20 µl/mouse). On days 35 and 41, the mice were challenged with OVA alone (10 µg/mouse) 
and analyzed 24 h after the last challenge. Abs, antibodies. (B) Total BALF cell count (left) and relative percentages of eosinophils (middle) and neutrophils 
(right) within BALF from the indicated mice. (C) Histological scores from the lungs of the indicated mice. (D) BLN-derived lymphocytes from the indicated 
mice were restimulated with 50 µg/ml OVA, and the concentrations of the indicated cytokines in the supernatant were measured by ELISA. (E) OVA-specific  
antibodies in the sera of the indicated mice including IgE (left), IgG1 (middle), or IgG2a (right). Representative data from one of two independent experi-
ments, with three to four mice per group, are shown. P-values for J18/ + OVA/HDE vs. J18/ + OVA and for J18/ + OVA/HDE vs. BALB/c + OVA/
HDE are indicated, where the difference is statistically significant (P, * < 0.05; P, ** < 0.01). Error bars indicate mean ± SEM.1156 NKT cell antigens in dust induce inflammation | Wingender et al.
and J18/ mice vaccinated with OVA alone displayed little 
evidence of pulmonary inflammation upon airway allergen 
challenge (Fig. 4, B and C; and Fig. S2), and their OVA-specific 
immune responses were similar (Fig. 4, D and E). In compari-
son with wild-type mice i.n. vaccinated with OVA alone, 
mice vaccinated with OVA and HDE standard (OVA/HDE) 
developed  significantly  stronger  airway  inflammation  and 
immune responses (Fig. 4, B–E). Consistent with a previous 
study, the HDE standard acted as a Th2-biasing mucosal ad-
juvant in this asthma model (Boasen et al., 2005) as OVA/
HDE immunized wild-type mice developed eosinophil-rich 
inflammatory responses after airway allergen challenge and 
robust OVA-specific Th2 cytokine and IgE responses (Fig. 4, 
B–E). However, other immune parameters were also increased, 
including IFN- and IL-17A synthesis by OVA-stimulated 
bronchial LN (BLN) cells (Fig. 4 D). Finally, although the 
HDE standard retained some adjuvant activity in J18/ 
mice (Fig. 4, B–E), immune responses to i.n. OVA/HDE 
vaccination, as well as airway inflammation after OVA chal-
lenge, were markedly attenuated compared with those of 
wild-type mice. (Fig. 4, B–E). Collectively, these observations 
indicate that V14i NKT cells played a major role in mediating 
the adjuvant activities of the HDE standard in this mouse model 
of allergen-induced airway inflammation.
Synergistic activation of lung V14i NKT and CD4 T cells
Having established an important role for V14i NKT cells in 
mediating the adjuvant activity of the HDE standard, we tested 
their short-term response to i.n. HDE challenge. Broncho-
alveolar lavage fluid (BALF) and lung lymphocytes were ana-
lyzed 24 h after a single challenge with HDE, but no significant 
differences in V14i NKT cell numbers, phenotype, or cyto-
kine production in the lung or BLNs were detected (Fig. 5 A 
and not depicted). However, in the BALF, the total number of 
V14i NKT cells and their expression of CD69 increased 
significantly 24 h after a single HDE challenge, although cyto-
kine synthesis did not increase (Fig. 5 A and not depicted).
Given that we observed only limited V14i NKT cell ac-
tivation and no activation of conventional T cells after a single 
airway exposure to HDE, we next considered whether these 
cellular responses would be more pronounced at the end of 
the sensitization phase of experiments described in Fig. 4 A. 
Therefore, mice were administered reagents on three occa-
sions, at weekly intervals. However, rather than allowing the 
adaptive response to develop further, mice were sacrificed on 
day 15, 1 d after the third vaccination with OVA, HDE, or 
OVA together with HDE. Whereas the phenotype of lung 
V14i NKT cells from mice vaccinated with OVA alone did 
not differ from control mice, we observed clear signs of V14i 
NKT cell activation in the lungs of mice treated either with 
HDE or OVA/HDE (Fig. 5 B). In particular, CD69 was up-
regulated and CD122 was down-regulated on V14i NKT 
cells (Fig. 5 B). Furthermore, we detected a higher percentage 
of CD4-negative V14i NKT cells in the lungs of mice vac-
cinated with HDE, and this finding was even more pronounced 
after OVA/HDE vaccination (Fig. 5 B and Fig. S3 A), suggesting 
either the selective recruitment and/or expansion of this sub-
set or the down-regulation of CD4 expression by  V14i NKT 
cells. Importantly, by intracellular cytokine staining, we could 
detect significantly more cytokine-producing lung  V14i NKT 
cells after challenge with OVA/HDE than with OVA or HDE 
alone (Fig. 5 C), and this was true not only for Th2 cytokines 
but also for Th1 cytokines and IL-17A. These observations sug-
gest that the concurrent adaptive immune response against 
OVA enhanced cytokine production by activated  V14i NKT 
cells. The CD4-negative subset of V14i NKT cells produced 
most of the cytokines, a trend which was especially prominent 
for IL-17A (Fig. 5 D and Fig. S3 B).
Without additional ex vivo stimulation, we could also 
detect cytokine production by a subset of CD44high memory 
CD4 T cells isolated from the lungs of vaccinated mice, and 
it was significantly higher in mice receiving OVA and HDE 
than in those receiving OVA or HDE alone (Fig. 5, E and F). 
The CD44high population of conventional TCR-+ T cells 
outnumbered V14i NKT cells by 10:1 in the lung (unpub-
lished data). Given the similarly elevated percentages of cyto-
kine-producing cells within this population (Fig. 5 F), we 
conclude that most of the cytokine-producing TCR-+ T 
cells detected after challenge with OVA/HDE were conven-
tional CD4 T cells. Importantly, cytokine production by CD4+ 
CD44high T cells was almost completely abrogated in J18/ 
mice (Fig. 5, E and F), indicating a crucial role for V14i 
NKT cells in the induction of the conventional CD4+ T cell 
response in the lung. Collectively, these observations demon-
strate synergy between V14i NKT cell and conventional CD4 
T cell responses in mice i.n. vaccinated with OVA and HDE.
DISCUSSION
We have shown that a majority of HDEs tested contain anti-
gens capable of activating mouse  V14i NKT cell hybridomas 
and  human V24i  NKT  cell  lines.  Stimulation  of  mouse 
V14i NKT cell hybridomas was shown to be CD1d depen-
dent and not dependent on TLR agonists present in HDEs. 
Activation of V14i NKT cells also was seen in vivo after in-
jection of BM-DCs pulsed with an HDE standard containing 
high levels of activity. Furthermore, in a mouse model of air-
way inflammation, the HDE standard had adjuvant activity 
that was largely V14i NKT cell dependent. Additionally, al-
though i.n. delivery of OVA or HDE standard alone led to some 
degree of lung CD4 cell and V14i NKT cell activation, in-
jection of these reagents together had synergistic effects on 
cytokine production by both cell types.
For several years, the only antigens identified that acti-
vated iNKT cells included -GalCer and its derivatives, but 
the distribution of iNKT cell antigens in the microbiota, and 
more generally in the environment, remains incompletely char-
acterized.  Although  the  finding  of  iNKT  cell  antigens  in 
Sphingomonas suggested that antigens could be found in sea-
water and soil, in this study, we have made the surprising 
finding that a significant amount of antigenic activity appears 
to be present in many households as well. An unresolved is-
sue is the origin of the iNKT cell antigens detected in HDEs. JEM Vol. 208, No. 6 
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farinae or Dermatophagoides pteronyssinus did not stimulate 
V14i NKT cell hybridomas (unpublished data), suggesting 
that house dust mites are not an important source of iNKT 
Although house dust mites have been shown to stimulate the 
innate and adaptive immune systems, in preliminary experi-
ments, we found that whole body extracts of Dermatophagoides 
Figure 5.  Synergistic activation of lung V14i NKT cells and CD4 T cells. (A) BALB/c mice were challenged once with HDE, and the surface ex-
pression of CD69 on iNKT cells from lung and BALF was determined 18 h later. The numbers in the histograms denote the geometric mean values of CD69 
on iNKT cells. Light gray, closed histogram: BALB/c control; solid line, open histogram: BALB/c challenged with HDE. (B–F) BALB/c mice and J18/ on 
the BALB/c background were vaccinated three times, once per week (days 0, 7, and 14) with chicken OVA alone (100 µg/mouse), HDE alone, or with OVA 
together with HDE and analyzed on day 15. Representative data of two or three independent experiments, with two to five mice per group, are shown.  
(B) Surface expression of CD69, CD122, and CD4 on lung iNKT cells from the indicated groups. The numbers in the histograms denote the geometric mean 
values of the indicated surface molecules on iNKT cells. (C) Cytokine production of lung iNKT cells ex vivo after the indicated treatments. Lymphocytes 
were kept 2 h in the presence of degranulation inhibitors to accumulate intracellular cytokines without further stimulation. The graph summarizes data 
from two or three independent experiments, with three to four mice per group. All cytokine values obtained from the OVA/HDE group were significantly 
different (P < 0.05) from the values obtained with the other treatments. (D) IL-17A production of lung CD4+ and CD4 iNKT cells from control mice 
(BALB/c ctr) or from mice challenged with OVA/HDE. (E) CD44 expression and IL-17A production of lung conventional CD4 T cells (CD19 iV14 CD8 
TCR-+ CD4+) from BALB/c or J18/ mice challenged with OVA/HDE. (F) Cytokine production of lung CD44high conventional CD4 T cells (CD19 iV14 
CD8 TCR-+ CD4+) ex vivo after the indicated treatments. Lymphocytes were kept 2 h in the presence of degranulation inhibitors to accumulate intra-
cellular cytokines without further stimulation. The graph summarizes data from two or three independent experiments, with three to four mice per group. 
All cytokine values obtained from the BALB/c + OVA/HDE group were significantly different (P < 0.05) from the values obtained from the J18/ + OVA/
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have been implicated in asthma causation in other models 
(Bilenki et al., 2004; Meyer et al., 2006; Pichavant et al., 2008; 
Matangkasombut et al., 2009).
Importantly, our data revealed a synergy in the cytokine 
responses of V14i NKT cells and conventional CD4 T cells 
in the lung after OVA/HDE vaccination (Fig. 5). It has been 
reported previously that concurrent activation of iNKT cells 
with glycolipid antigen can augment the adaptive immune 
responses of both T and B cells (Cerundolo et al., 2009). The 
novel finding we report here is the enhancing effect of an on-
going adaptive immune response on the simultaneous activa-
tion of V14i NKT cells. Three weekly i.n. exposures to HDE 
standard alone induced less cytokine production by V14i 
NKT cells in vivo than i.n. vaccination with OVA/HDE (Fig. 5). 
As OVA does not contain iNKT cell antigens, we hypothesize 
that the adaptive anti-OVA response functioned to augment 
the response of V14i NKT cells, although the mechanism 
mediating enhanced  V14i NKT cell cytokines remains to be 
determined. This positive feedback of adaptive immune re-
sponses on innate-like iNKT cells may have been missed pre-
viously because relatively early responses were analyzed, whereas 
in this study a more prolonged immunization protocol was 
used. Innate cell-derived cytokines IL-12 and IFN-/ have 
been reported to augment CD1d-dependent iNKT cell acti-
vation (Brigl et al., 2003; Mattner et al., 2005; Paget et al., 
2007), which was especially crucial for stimulation with pre-
sumably weak antigens. However, in our experiments, activa-
tion of the innate immune system by TLR-Ls present in the 
HDE standard apparently had a far weaker synergistic effect 
on antigen-specific V14i NKT cell activation than the on-
going adaptive immune response elicited by OVA.
In this context, it might be surprising that the response of 
conventional CD4+ T cells was comparably low when mice 
were i.n. immunized with HDE standard alone or OVA alone. 
However, although the 100-µg OVA vaccination dose pro-
vided ample T cell antigens, it provided hardly stimulating li-
gands for the innate immune system. In contrast, the 20-µl HDE 
dose used for these experiments should have provided larger 
amounts of danger signals, but based on our reasoning, only 
limited amounts of any one specific T cell antigen. HDEs are 
known to contain several traditional allergens, including house 
dust mite, molds, and animal dander. However, based on re-
ported concentrations of common indoor allergens found 
in house dust (Cho et al., 2006), we estimate the delivery of 
0.16 µg of each relevant allergen per dose of HDE standard, or 
1/625 of the OVA dose used for these experiments.
In summary, our novel findings include, first, the discovery 
that antigens for mouse and human iNKT cells are widely 
distributed in living indoor environments. Second, we dem-
onstrate that the adjuvant activity of HDEs is largely depen-
dent on V14i NKT cells. Third, in the context of repeated 
antigen exposures in the lung, not only does V14i NKT cell 
activation contribute to the response by conventional CD4+ 
T cells, but the conventional CD4+ T lymphocyte response 
augments iNKT cell activation as well. Based on these find-
ings, we suggest that the airway milieu induced by repeated 
cell antigen. Preliminary results of biochemical analyses sug-
gest that the V14i NKT cell–specific antigenic activities of 
at least some HDEs are not glycosphingolipid (unpublished 
data). However, a more thorough analysis of many different 
HDEs will be required to determine whether this conclusion 
can be generalized.
As several bacteria contain iNKT cell antigens, we con-
sider it most likely that the immunostimulatory material for 
iNKT cells detected in HDEs was of bacterial origin. HDEs 
are known to contain a variety of microbial products, and in 
a previous publication, we reported that HDEs have MyD88-
dependent adjuvant activity (Ng et al., 2006). The results 
presented in this study demonstrate a predominant role for 
V14i NKT cells in mediating the stimulatory effect of HDEs. 
These findings are not contradictory, as the activation of iNKT 
cells to putatively weak self-antigens requires a synergistic 
contribution of MyD88 signals (Mattner et al., 2005), leading 
to cytokine secretion by APCs (Brigl et al., 2003; Paget et al., 
2007). Therefore, we hypothesize that APC-derived cyto-
kines could also be required for an iNKT cell response to micro-
bial  antigens  that  are  weak  and/or  at  low  concentration. 
However, the presence of V14i NKT cell antigen detected 
in the CD1d-coated plate assay and the ability of DCs defi-
cient for TLR signaling to stimulate iNKT cells in vivo sug-
gest that the iNKT cell–dependent adjuvant activity of HDEs 
required antigen recognition.
Regardless of the nature of the antigen, the variation in 
the ability of different extracts to stimulate iNKT cells sug-
gests diversity in the composition of HDEs from different homes 
(Figs. 1 and 2). Furthermore, although most HDEs activated 
iNKT cells in all the in vitro assays, some exhibited mouse 
versus human species specificity or a requirement for a par-
ticular V gene, suggesting that the iNKT cell antigens con-
tained within these HDEs could have differing TCR affinities 
or that they preferentially activate subsets of these cells. We 
speculate that the concentration and/or potency of iNKT 
cell antigens found in different environments could contrib-
ute to the striking differences in the frequency of iNKT 
cells observed in the peripheral blood of normal individu-
als (Kronenberg, 2005).
A surprising result from these experiments was the degree 
to which the adjuvant activity of our HDE standard was de-
pendent on the presence of V14i NKT cells (Fig. 4). In ana-
lyzing the response to OVA alone versus OVA/HDE in J18/ 
mice, an iNKT cell–independent adjuvant effect was observed; 
however, this effect was relatively minor. In contrast, the promi-
nent role of V14i NKT cells in our i.n. sensitization experi-
ments is consistent with other studies showing an important 
effect of iNKT cells on immune responses in the lung, not only 
in models of asthma and chronic obstructive pulmonary dis-
ease (Lisbonne et al., 2003; Bilenki et al., 2004; Kim et al., 2008; 
Kim et al., 2009; Pichavant et al., 2008) but also in the response 
to  infectious  agents  (Nieuwenhuis  et  al.,  2002;  Kawakami   
et al., 2003). In the context of i.n. sensitization with OVA/HDE, 
production by V14i NKT cells of all cytokines tested was 
increased (Fig. 4), including Th2 cytokines and IL-17A, which JEM Vol. 208, No. 6 
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iNKT cell hybridomas on CD1d-coated plates was performed as described 
previously (Sidobre et al., 2002). Aliquots of individual HDEs found to have 
high levels of iNKT cell ligands were combined to prepare an HDE standard 
that was used for the in vivo experiments. Human PBMCs were obtained from 
a healthy donor in accordance with the La Jolla Institute for Allergy and Immu-
nology Normal Blood Donor Umbrella Program (#VD-057-0909). The 
human NKT lines #59 and #2225 were generated from normal human donor 
PBMCs and maintained as described previously (Rogers et al., 2004). In 
brief, iNKT cells were stimulated every 9–12 d with -GalCer–pulsed, irra-
diated (3,000 R) PBMCs and 30 ng/ml recombinant human IL-2 (BioLegend). 
TCR expression was >95% V24+ V11+. To detect iNKT cell antigens,   
human PBMCs (4 × 106 cells in 0.4 ml) were pulsed for 4–20 h at 37°C in 
a CO2 incubator with 1 ng/ml -GalCer or 1:10 dilutions of the indicated 
HDEs in AIM V medium (Invitrogen). Cells were then washed twice, and 
2 × 105 pulsed PBMCs were co-cultured in duplicate with 4 × 104 iNKT cells 
in 200 µl in 96-well flat-bottom plates. After 72 h, human GM-CSF in su-
pernatants was determined by ELISA using coating and detection antibodies 
(clones BVD2-23B6 and BVD2-21C11) from BioLegend. Recombinant 
cytokines were purchased from BD. In brief, Nunc plates (Thermo Fisher 
Scientific) were coated overnight with 1–2 µg/ml of coating antibody in car-
bonate buffer. Wells were blocked with PBS + 1% BSA before the addition of 
test supernatants. Bound cytokine was detected with biotinylated anticytokine 
antibody followed by streptavidin–horseradish peroxidase (SouthernBiotech). 
Wells were developed with TMB chromogen (Dako) and stopped with 2 N 
sulfuric acid before reading at 450 nm.
DC adoptive transfer experiments. Mouse BM-DCs were prepared by 
culturing BM progenitor cells from mice deficient for both MyD88 and Trif 
(BM-DCDKO) with mouse GM-CSF (PeproTech) for 6–8 d. BM-DCDKO 
were incubated in vitro with 750 ng/ml LPS, 50 ng/ml -GalCer, or 50 µl/ml 
HDE standard for 4–5 h and washed, and 5 × 105 pulsed BM-DCDKO were 
injected i.v. into naive recipient mice. iNKT and NK cell responses were 
analyzed 12–16 h later by flow cytometry. For CD1d blockade in vivo, 
200 µg -CD1d antibodies (1B1) were injected i.v. together with the indi-
cated BM-DCs.
Flow cytometry. For staining of cell surface molecules, cells were sus-
pended in staining buffer (PBS, 1% BSA, and 0.01% NaN3) and stained with 
fluorochrome-conjugated mAb (0.1–1 µg/106 cells) for 15 min in a total volume 
of 50 µl. FcR-blocking antibody -CD16/32 (2.4G2) and unconjugated 
rat IgG (Jackson ImmunoResearch Laboratories, Inc.) were added to prevent 
nonspecific binding. If biotin-conjugated mAb was used, cell-bound mAb 
was detected with streptavidin conjugates (1:200) in a second incubation step. 
Staining of T cells with -GalCer–loaded CD1d tetramers was performed as 
described previously (Matsuda et al., 2000). In brief, cells were stained with 
the tetramer together with other surface mAbs in staining buffer at 4°C for 
30 min. For analysis of intracellular cytokines, cells were fixed and permeabi-
lized using the Cytofix/Cytoperm reagents (BD) for 10 min at 37°C. Cells 
were washed twice and incubated for 30 min with fluorochrome-conjugated 
mAb and unconjugated rat IgG in Perm/Wash solution (BD), which was 
followed by an additional 5-min incubation in Perm/Wash solution without 
mAb. For in vitro experiments intended for intracellular staining, GolgiPlug 
and GolgiStop (BD) were added for the last 4 h of incubation. For ex vivo 
experiments intended for intracellular staining of IL-17A, lymphocytes were 
cultured for 2 h in the presence of GolgiPlug and GolgiStop. Cells were 
analyzed with FACSCalibur or LSR II (BD), and data were processed with 
CellQuest Pro (BD) or FlowJo (Tree Star) software. Graphs derived from 
digital data are displayed on a biexponential scale.
Airway allergen sensitization and challenge model. Naive mice (n = 
4–6 per group) received a series of three weekly i.n. 100-µg OVA vaccina-
tions with or without 20 µl HDE standard. 3 wk after completing sensitization, 
all mice received two i.n. 10-µg OVA challenges, delivered 6 d apart, and airway 
and immunological responses were assessed the next day (experimental out-
line in Fig. 4 A). Mice were lightly anesthetized (isoflurane; Abbott Laboratories) 
stimulation with iNKT and conventional CD4 T cell antigens 
could act as a feed-forward loop that might contribute to the 
genesis of asthma and other allergic diseases, selectively in those 
environments more enriched for these antigens.
MATERIALS AND METHODS
Mice. All mice were housed under specified pathogen–free conditions at the 
animal facilities of the La Jolla Institute for Allergy and Immunology and the 
University of California, San Diego in accordance with the Institutional 
Animal Care Committee guidelines. All experiments were performed in an 
Association for Assessment and Accreditation of Laboratory Animal Care Inter-
national–accredited facility with prior approval of the La Jolla Institute for 
Allergy  and  Immunology Animal  Care  Committee  (Institutional Animal 
Care and Use Committee) in accordance with the Public Health Service 
Policy. C57BL/6 and BALB/c mice were purchased from the Jackson Labo-
ratory. MyD88 (Adachi et al., 1998)- and Trif (Lps2; Hoebe et al., 2003; 
Yamamoto et al., 2003)-deficient animals have been described previously and 
were used as double-deficient animals. B6.129-Tcra-Jtm1Tgi (J18/) mice 
(Cui et al., 1997) and CD1d-deficient mice (CD1d/; Mendiratta et al., 
1997) on the C57BL/6 background were the gift of M. Taniguchi (RIKEN 
Institute, Yokohama, Japan) and L. Van Kaer (Vanderbilt University, Nashville, 
TN), respectively, and were crossed onto the BALB/c background.
Reagents and mAbs. -GalCer ([2S,3S,4R]-1-O-[a-d-galactopyranosyl]-
N-hexacosanoyl-2-amino-1,3,4-octadecanetriol) was obtained from the 
Kirin pharmaceutical research corporation. Lipopeptide Pam-3-Cys (P-3-C; 
EMC Microcollections) and Escherichia coli 026-B6 LPS (Sigma-Aldrich) 
were purchased from commercial vendors. Whole body extracts from the 
dust mites D. farinae and D. pteronyssinus were obtained from Greer Laborato-
ries. mAbs against the following mouse antigens were used in this study: CD1d 
(1B1), CD3- (145.2C11; 17A2), CD4 (GK1.5; RM4-5), CD8 (53-6.7; 
5H10), CD11b (M1/70), CD11c (HL3), CD19 (1D3; 6D5), CD24 (M1/69), 
CD25  (PC61.5),  CD44  (IM7),  CD45.1  (A20),  CD45.2  (104),  CD45R 
(B220; RA3-6B2), CD69 (H1.2F3), TCR- (H57-597), Thy1.2 (30-H12; 
53–2.1), NK1.1 (PK136), Ly6CG (Gr1), TNF (MP6-XT22), IL-4 (11B11), 
and IFN- (XMG1.2). Antibodies were purchased from BD, BioLegend, 
eBioscience, or Invitrogen. The mAbs against human V24 (C15) and V11 
(C21) were obtained from Beckman Coulter. Antibodies were biotinylated 
or conjugated to Pacific blue, Alexa Fluor 405, Pacific orange, V500, FITC, 
Alexa Fluor 488, PE, PE–Texas red, PerCP-Cy5.5, PE-Cy7, APC, Alexa   
Fluor  647,  Alexa  Fluor  700,  APC-Cy7,  APC–Alexa  Fluor  750,  or  APC-
eFluor780. Anti–mouse CD16/32 antibody used for Fc receptor blocking 
was isolated in our laboratory. Purification of mouse CD1d, preparation of 
PE- and APC-conjugated -GalCer–loaded CD1d tetramers, and staining of 
cells were performed as described previously (Matsuda et al., 2000).
Preparation of HDEs. Methods used for the collection and processing of 
house dust samples have been described in detail previously (Ng et al., 2006). 
In brief, with approval from our institution’s human subjects committee, dust 
samples were obtained by vacuuming a single carpeted bedroom within sub-
urban homes. Collected house dust was run through a course sieve to remove 
large particulate matter and suspended in sterile PBS at 100 mg/ml. House 
dust suspensions were then placed on a rotor at room temperature for 18 h, 
filtered through glass wool, and finally through 0.22-µm Steriflip filters to 
obtain sterile HDEs. For select experiments, we prepared an HDE standard 
by combining individual HDEs found to have high levels of iNKT cell anti-
gen based on a mouse iNKT cell hybridoma assay that is described in the 
next section.
Cell  lines  and  CD1d-coated  plate  assay. The CD1d-reactive V14i 
NKT cell hybridomas DN3A4-1.2, DN3A4-1.4, and 2H4, as well as the 
CD1d-reactive non-iNKT cell hybridoma 24 have been described previously 
(Brossay et al., 1998; Burdin et al., 2000). The OVA (OVA257–264)-specific hy-
bridoma B3Z (Sanderson and Shastri, 1994) was a gift of S. Schoenberger 
(La Jolla Institute for Allergy and Immunology, La Jolla, CA). Stimulation of 1160 NKT cell antigens in dust induce inflammation | Wingender et al.
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before the i.n. or pharyngeal-laryngeal delivery, and all reagents were deliv-
ered in a total volume of 30 µl PBS. 18 h after the final OVA challenge, mice 
were sacrificed, lungs were lavaged with 800 µl PBS, and BALF was col-
lected. Total BALF cell counts were determined with a hemocytometer. 
In addition, BALF cytospin slides were prepared, fixed in acetone, and Wright-
Giemsa stained. A blinded observer determined the percentage of eosino-
phils, neutrophils, and mononuclear cells on each slide by counting a minimum 
of 150 cells in random high-power fields with a light microscope (Carl Zeiss). 
Lung tissue was flash frozen, cryosectioned, acetone-fixed onto poly-L-
lysine–coated slides, and stained with hematoxylin-eosin, peroxidase/3,3-diami-
nobenzidine, and periodic acid Schiff by standardized techniques.  To quantitate 
peribronchial inflammation, eosinophil infiltration, and airway mucous produc-
tion, a scoring system (0–5) was devised in which a blinded observer scored 
four to eight airways per mouse for each of these parameters. Mean inflam-
mation scores were determined by averaging the total cellular infiltration, eosin-
ophil infiltration, and airway mucous production scores for each mouse 
group as described previously (Ng et al., 2006; Lam et al., 2008).
Sera were obtained from vaccinated and airway allergen–challenged 
mice at sacrifice to measure antigen-specific IgG1, IgG2a, and IgE levels by 
ELISA as described previously (Ng et al., 2006; Lam et al., 2008). Samples 
were compared with high-titer anti-OVA IgG1, IgG2a, and IgE standards, 
with end point titrations of 1.2 × 107 U/ml for IgG1, 1.5 × 105 U/ml for 
IgG2a, and 512 U/ml for IgE. To remove IgG and improve the sensitivity of 
the OVA-specific IgE ELISA, serum samples were preincubated with pro-
tein  G–Sepharose  beads  (Pharmacia).  OVA-specific  BLN  cytokine  re-
sponses were assessed as described previously (Ng et al., 2006; Lam et al., 
2008). In brief, BLNs harvested from each group of experimental mice 
were pooled, and single-cell suspensions were prepared by enzymatic diges-
tion with 300 U/ml Collagenase VIII (Sigma-Aldrich) and 1.5 µg/ml 
DNase-I (Sigma-Aldrich). BLN cells were cultured in triplicate at 106 cells/
ml in media with or without 50 µg/ml OVA for 72 h before harvesting su-
pernatants. Cytokine levels in culture supernatants were determined by 
ELISA using BD reagents according to the manufacturer’s recommenda-
tions. BLN cytokine responses were calculated by subtracting background 
cytokine production (generally ≤0.05 ng/ml) from responses of BLN cells 
cultured with OVA.
In some experiments, lymphocyte responses in the lung and BALF were 
analyzed 16 h after a single challenge or after the end of the sensitization 
phase (three weekly challenges). Lung tissue was first cut into small sections 
and enzymatically digested with Collagenase VIII and DNase-I, as described 
for BLNs in the previous paragraph.
Statistical analysis. Results are expressed as mean ± SEM. Comparisons 
were drawn using a two-tailed Student’s t test (Excel; Microsoft) or analy-
sis of variance test (Prism; GraphPad Software). Each experiment was re-
peated at least twice. Graphs were generated with Prism software.
Online supplemental material. Fig. S1 shows the trans-activation of NK 
cells, as measured by up-regulation of CD69, after the injection of BM-
DCDKO as described in Fig. 1. Fig. S2 presents representative major basic pro-
tein– and periodic acid Schiff–stained lung sections of mice described in Fig. 4. 
Fig. S3 summarizes the percentage of CD4+ and CD4 iNKT cells in the 
lung of experimental mice and their contribution to cytokine responses 
described in Fig. 5. Online supplemental material is available at http://www 
.jem.org/cgi/content/full/jem.20102229/DC1.
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